Mariko Deguchi

Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy

Koichiro Yamamoto, Seiji Hokimoto, Tadasuke Chitose et al. · Journal of Cardiology · 2010 · 100 citations

Medicine, Cardiology, Pharmacology +17

Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis

Naoki Ogusu, Junji Saruwatari, Hiroo Nakashima et al. · PLoS ONE · 2014 · 38 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention

Takamichi Ono, Koichi Kaikita, Seiji Hokimoto et al. · Thrombosis Research · 2011 · 34 citations

Medicine, Pharmacokinetics, Pharmacology +17

Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines

Keisuke Gotanda, Takeshi Hirota, Jumpei Saito et al. · Scientific Reports · 2016 · 34 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +10

Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p‐Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs

Ichiro Ieiri, Shyohei Tsunemitsu, Kazuya Maeda et al. · The Journal of Clinical Pharmacology · 2013 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +8